KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Change in Taxes: 2009-2011

Historic Change in Taxes for Alnylam Pharmaceuticals (ALNY) over the last 3 years, with Dec 2011 value amounting to -$10.7 million.

  • Alnylam Pharmaceuticals' Change in Taxes fell 92.37% to -$10.7 million in Q1 2011 from the same period last year, while for Mar 2011 it was $5.5 million, marking a year-over-year change of. This contributed to the annual value of -$10.7 million for FY2011, which is 200.00% down from last year.
  • Per Alnylam Pharmaceuticals' latest filing, its Change in Taxes stood at -$10.7 million for FY2011, which was down 200.00% from $10.7 million recorded in FY2010.
  • Alnylam Pharmaceuticals' 5-year Change in Taxes high stood at $10.7 million for FY2010, and its period low was -$10.7 million during FY2011.
  • Moreover, its 3-year median value for Change in Taxes was -$467,000 (2009), whereas its average is -$155,667.
  • In the last 5 years, Alnylam Pharmaceuticals' Change in Taxes soared by 2,384.58% in 2010 and then crashed by 200.00% in 2011.
  • Over the past 3 years, Alnylam Pharmaceuticals' Change in Taxes (Yearly) stood at -$467,000 in 2009, then surged by 2,384.58% to $10.7 million in 2010, then crashed by 200.00% to -$10.7 million in 2011.